Cargando…

Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trial

BACKGROUND: Rituximab and tacrolimus are therapies reserved for patients with frequently relapsing or steroid-dependent nephrotic syndrome who have failed conventional steroid-sparing agents. Given their toxicities, demonstrating non-inferiority of rituximab to tacrolimus may enable choice between t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mathew, Georgie, Sinha, Aditi, Ahmed, Aijaz, Grewal, Neetu, Khandelwal, Priyanka, Hari, Pankaj, Bagga, Arvind
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919684/ https://www.ncbi.nlm.nih.gov/pubmed/35286456 http://dx.doi.org/10.1007/s00467-022-05475-8

Ejemplares similares

Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020)

Prevalence of Bladder and Bowel Dysfunction in Toilet-Trained Children With Urinary Tract Infection and/or Primary Vesicoureteral Reflux: A Systematic Review and Meta-Analysis
por: Meena, Jitendra, et al.
Publicado: (2020)

Short Course of Daily Prednisolone During Upper Respiratory Tract Infection for Children With Relapsing Steroid Sensitive Nephrotic Syndrome
por: Mathew, Joseph L., et al.
Publicado: (2022)

Long-Term Efficacy and Safety of Rituximab Versus Tacrolimus in Children With Steroid Dependent Nephrotic Syndrome
por: Basu, Biswanath, et al.
Publicado: (2023)

Children with Steroid Dependent Nephrotic Syndrome: Rituximab or Tacrolimus? It’s All in the Timing
por: Qader, Md Abdul, et al.
Publicado: (2023)

Steroid Sensitive Nephrotic Syndrome: Revised Guidelines
por: Sinha, Aditi, et al.
Publicado: (2021)

Revised guidelines for management of steroid-sensitive nephrotic syndrome
por: Bagga, Arvind
Publicado: (2008)

SARS-CoV-2 infection in children with nephrotic syndrome
por: Krishnasamy, Sudarsan, et al.
Publicado: (2022)

Experience with tacrolimus in children with steroid-resistant nephrotic syndrome
por: Butani, Lavjay, et al.
Publicado: (2009)

Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome
por: Sinha, A., et al.
Publicado: (2013)

Anti-factor H antibody associated hemolytic uremic syndrome following SARS-CoV-2 infection
por: Khandelwal, Priyanka, et al.
Publicado: (2022)

Rituximab therapy in adults with steroid-dependent nephrotic syndrome
por: Zhong, Hongzhen, et al.
Publicado: (2019)

Early Use of Rituximab in Calcineurin Inhibitor–Refractory and Steroid-Resistant Nephrotic Syndrome
por: Sinha, Rajiv, et al.
Publicado: (2020)

Mutations in membrane cofactor protein (CD46) gene in Indian children with hemolytic uremic syndrome
por: Khandelwal, Priyanka, et al.
Publicado: (2018)

Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome
por: Sinha, Rajiv, et al.
Publicado: (2021)

Comparison of rituximab, cyclophosphamide, and tacrolimus as first steroid-sparing agents for complicated relapsing/steroid-dependent nephrotic syndrome in children: an evaluation of the health-related quality of life
por: Wang, Li, et al.
Publicado: (2022)

Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea
por: Ahn, Yo Han, et al.
Publicado: (2018)

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome
por: Angeletti, Andrea, et al.
Publicado: (2022)

Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials
por: Iijima, Kazumoto, et al.
Publicado: (2017)

Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth
por: Topaloğlu, Rezan, et al.
Publicado: (2019)

Rituximab treatment for difficult-to-treat nephrotic syndrome in children:a multicenter, retrospective study
por: TAŞDEMİR, Mehmet, et al.
Publicado: (2021)

Long-term repeated rituximab treatment for childhood steroid-dependent nephrotic syndrome
por: Kim, Ji Hyun, et al.
Publicado: (2017)

Hypokalemia After Rituximab Administration in Steroid-Dependent Nephrotic Syndrome: A Case Report
por: Guzzi, Francesco, et al.
Publicado: (2020)

Population Pharmacokinetics of Rituximab in Pediatric Patients With Frequent-Relapsing or Steroid-Dependent Nephrotic Syndrome
por: Chen, Yewei, et al.
Publicado: (2021)

Necrotizing Fasciitis: A Side Effect of Rituximab Administration in Steroid-Dependent Nephrotic Syndrome
por: Safdar, Osama Yousif, et al.
Publicado: (2022)

Therapeutic trials in difficult to treat steroid sensitive nephrotic syndrome: challenges and future directions
por: McKay, Ashlene M., et al.
Publicado: (2022)

Cost-Effectiveness of Administering Rituximab for Steroid-Dependent Nephrotic Syndrome and Frequently Relapsing Nephrotic Syndrome: A Preliminary Study in Japan
por: Takura, Tomoyuki, et al.
Publicado: (2017)

Intravenous Immunoglobulin and Methylprednisolone Refractory Multisystem Inflammatory Syndrome in Children (MIS-C) in Steroid-Dependent Nephrotic Syndrome Following Rituximab
por: Pal, Priyankar, et al.
Publicado: (2022)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

Efficacy and Safety of Cyclosporine versus Tacrolimus in Steroid and Cyclophosphamide Resistant Nephrotic Syndrome: A Prospective Study
por: Prasad, N., et al.
Publicado: (2018)

SARS-CoV-2 infection in children with chronic kidney disease
por: Krishnasamy, Sudarsan, et al.
Publicado: (2021)

Systematic Review and Meta-Analysis of Rituximab for Steroid-Dependent or Frequently Relapsing Nephrotic Syndrome in Children
por: Gao, Xia, et al.
Publicado: (2021)

The outcome of rituximab in treating steroid dependent nephrotic syndrome.: Histopathology and immunosuppressive drugs as predicting factors
por: Al Salloum, Abdullah A., et al.
Publicado: (2022)

Rituximab Treatment for Nephrotic Syndrome in Children
por: Iijima, Kazumoto, et al.
Publicado: (2014)

Effectiveness of rituximab in nephrotic syndrome treatment
por: Popko, Katarzyna, et al.
Publicado: (2017)

Difficulties in diagnosing severe Pneumocystis jiroveci pneumonia after rituximab therapy for steroid-dependent nephrotic syndrome
por: Czarniak, Piotr, et al.
Publicado: (2013)

The Efficacy and Safety of Rituximab for Childhood Steroid-Dependent Nephrotic Syndrome: A Systematic Review and Meta-Analysis
por: Liu, Sidi, et al.
Publicado: (2021)

Managing Children With Renal Diseases During the COVID-19 Pandemic
por: Vasudevan, Anil, et al.
Publicado: (2020)

Tacrolimus-induced mania in a patient with nephrotic syndrome
por: Kumar, Alok, et al.
Publicado: (2020)

Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment
por: Iwabuchi, Yuko, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_qo04mon7d2nck12mgv4ifm5qnn